Skin cancer phone apps aren't very accurate: study

Key points
- Smartphone applications that use algorithms to analyze skin lesions may not be very good at determining which ones are cancerous, a new study suggests.
- The apps are marketed as educational only and so aren't covered as medical devices under the Food and Drug Administration's regulations.
- But that may not stop some people from relying on the inexpensive tools instead of going to see a dermatologist, researchers said - which could mean slower diagnosis of potentially dangerous lesions.
- "There's no substitute, at this point, for a complete skin exam performed by an expert dermatologist for picking up melanoma as well as other skin cancers," said Dr.
Smartphone applications that use algorithms to analyze skin lesions may not be very good at determining which ones are cancerous, a new study suggests.
The apps are marketed as educational only and so aren't covered as medical devices under the Food and Drug Administration's regulations.
But that may not stop some people from relying on the inexpensive tools instead of going to see a dermatologist, researchers said - which could mean slower diagnosis of potentially dangerous lesions.
"There's no substitute, at this point, for a complete skin exam performed by an expert dermatologist for picking up melanoma as well as other skin cancers," said Dr. Karen Edison, a dermatologist from University of Missouri in Columbia who wasn't involved in the new study.
"Just sending a picture to someone you don't know anywhere in the world can be reassuring if it's very clear that (the lesion) is benign, so that's a good thing," she told Reuters Health, "but it's kind of fraught with other issues that we haven't grappled with adequately, I don't think."
For example, even if an app makes a correct diagnosis of melanoma, that doesn't necessarily help if the patient doesn't know where to get a biopsy or doesn't have insurance to pay for it, Edison said. "We're all for technology, but we need to keep it in perspective, and make it a tool."
For the new study, researchers used photos of 188 pre-diagnosed lesions - 60 melanomas and 128 benign lesions - to check the accuracy of four Smartphone apps made to look for melanoma in previously-taken images.
Three of those apps, which cost under $5 to own, use algorithms to determine whether a lesion is likely to be cancerous or not. The fourth sends images to a certified dermatologist for evaluation, at a price of $5 per lesion.
Of the three algorithm-based apps, the most accurate still missed 18 of the 60 melanomas, mistakenly classifying them as lower-risk, Dr. Laura Ferris from the University of Pittsburgh Medical Center in Pennsylvania and her colleagues reported Wednesday in JAMA Dermatology.
App users "need to know that that's a pretty big risk to take," Ferris said.
"If you delay removal or evaluation for your melanoma, it gets deeper, and the chance of it spreading and getting deadly really increases with time," she told Reuters Health.
The dermatologist consultation app did better than the others, misdiagnosing just one out of 53 evaluable images of cancerous lesions.
All but one of the apps classified more than half of the benign, non-cancerous lesions as problematic.
The researchers said they chose not to release the commercial names of the apps evaluated because their purpose was to determine the accuracy of this type of tool, in general.
The website of a similar company that markets an app for skin lesion analysis using real-time photos, SkinVision, cautions customers to, "Never disregard professional medical advice, or delay in seeking it, because of something you have read on SkinVision. Do not rely on information from SkinVision instead of seeking professional medical advice."
Written and revised by
Andrey Nailor, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Cancer →
NewsCan Aspirin, Other NSAIDs Lower Skin Cancer Risk?
Aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen and naproxen may help protect against certain types of skin cancer - including melanoma, the most dangerous form of this disease. The new…
1 June 2012
NewsAspirin 'may prevent skin cancer'
People who take aspirin tablets or similar painkillers on a regular basis cut their risk of developing skin cancer - including the most deadly type - malignant melanoma - by about 15%, research suggests. The work in the…
30 May 2012
NewsCommonly used painkillers may protect against skin cancer
A new study suggests that aspirin and other similar painkillers may help protect against skin cancer. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the findings indicate that…
30 May 2012





